| 注册
首页|期刊导航|肿瘤防治研究|中药单体及复方通过调控糖代谢重编程抗肺癌的作用机制研究进展

中药单体及复方通过调控糖代谢重编程抗肺癌的作用机制研究进展

王真 郭红磊 王爱迪 马霖 刘宝山

肿瘤防治研究2025,Vol.52Issue(12):1021-1028,8.
肿瘤防治研究2025,Vol.52Issue(12):1021-1028,8.DOI:10.3971/j.issn.1000-8578.2025.25.0405

中药单体及复方通过调控糖代谢重编程抗肺癌的作用机制研究进展

Research Progress on Mechanism of Chinese Herbal Monomers and Compound Formulas Against Lung Cancer Through Glucose Metabolic Reprogramming

王真 1郭红磊 2王爱迪 2马霖 2刘宝山2

作者信息

  • 1. 301617 天津,天津中医药大学研究生院
  • 2. 300052 天津,天津医科大学总医院中医科
  • 折叠

摘要

Abstract

Glucose metabolic reprogramming is important in promoting the occurrence and development of malignant tumors and meeting the high demands of the malignant proliferation of tumor cells.An in-depth investigation of the mechanism of glucose metabolic reprogramming in lung cancer is important for the development of effective therapeutic strategies for lung cancer.Traditional Chinese medicine(TCM)is characterized by multiple components,targets,and pathways and can exert antitumor effects through multiple mechanisms.This article illustrates systematically the mechanism of action of Chinese herbal monomers and compound formulas regulating glucose metabolic reprogramming in lung cancer and explores deeply their regulatory effects on key enzymes of glycolysis and metabolism-related signaling pathways,and their potential in overcoming the drug resistance of lung cancer.It aims to provide a reference basis for the study of therapeutic targets and mechanisms of action of TCM in prevention and treatment of lung cancer and theoretical sources for the research and development of new medicines.

关键词

中药/单体或复方/糖代谢重编程/肺癌/作用机制

Key words

Traditional Chinese medicine/Monomer or compound/Glucose metabolic reprogramming/Lung cancer/Mechanism

分类

医药卫生

引用本文复制引用

王真,郭红磊,王爱迪,马霖,刘宝山..中药单体及复方通过调控糖代谢重编程抗肺癌的作用机制研究进展[J].肿瘤防治研究,2025,52(12):1021-1028,8.

基金项目

National Natural Science Foundation of China(No.82374354) (No.82374354)

National Natural Science Foundation of China Youth Fund(No.82305127) 国家自然科学基金面上项目(82374354) (No.82305127)

国家自然科学基金青年基金(82305127) (82305127)

肿瘤防治研究

1000-8578

访问量0
|
下载量0
段落导航相关论文